This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:co-infections [06.07.2011] – paulalbert | home:diseases:co-infections [06.08.2011] – [Co-infections] paulalbert | ||
---|---|---|---|
Line 2: | Line 2: | ||
====== Co-infections ====== | ====== Co-infections ====== | ||
+ | < | ||
A variety of bacteria, fungi, and viruses are commonly described as co-infections. These include: // | A variety of bacteria, fungi, and viruses are commonly described as co-infections. These include: // | ||
- | Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections. | + | Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, |
+ | ===== Types ===== | ||
+ | * // | ||
+ | * // | ||
+ | * //Babesia// – //Babesia// is a protozoan parasite of the blood that causes a hemolytic disease known as Babesiosis. There are over 100 species of //Babesia// identified. | ||
+ | * //Candida albicans// – //Candida// is a fungus (a form of yeast) that plays a role in opportunistic oral and genital infections in humans. //C. albicans// biofilms readily form on the surface of implantable medical devices. Systemic fungal infections (fungemias) have emerged as important causes of morbidity and mortality in patients traditionally labelled as immunocompromised, | ||
+ | * cytomegalovirus | ||
+ | * // | ||
+ | * Epstein-Barr virus | ||
+ | * // | ||
===== Term can be ambiguous ===== | ===== Term can be ambiguous ===== | ||
Line 17: | Line 27: | ||
- | ===== Marshall Protocol targets co-infections ===== | + | ===== Marshall Protocol targets |
< | < | ||
- | Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes | + | Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes including |
{{section>: | {{section>: |